Company / Depreciation & Amortization
PALVELLA THERAPEUTICS, INC. Depreciation & Amortization History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.9M
FY2023
5-year range
$600.0K / $2.8M
FY2019-FY2023
Trend
-31.3%
vs FY2022
Sector context
#103 of 163
Health Care
What the data says
At $2M, PALVELLA THERAPEUTICS, INC.'s depreciation & amortization ranks #61 of 163 in the Health Care sector. Improved from $2M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2023 with a 5-year CAGR of +38.8%.
Improved from $2M to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +38.8%
- 10-Year CAGR
- -
Sector benchmark
#61 of 163 in Health CareTop 37% of 163This company $1.9M Sector average $219.4M
▼
-99.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.8%, indicating consistent growth.
- In FY2023, depreciation & amortization decreased 31.3% year-over-year.
- Ranks #103 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $1.9M | -31.3% |
| FY2022 | $2.8M | +31.9% |
| FY2021 | $2.1M | +250.0% |
| FY2020 | $600.0K | - |
| FY2019 | - | - |
| FY2018 | $369.0K | +2.2% |
| FY2017 | $361.0K | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 30, 2026